KANSAS CITY, Mo., Jan. 29, 2018 -- Caravan Health will be presenting a webinar discussing new health care policy changes, including the recent MedPAC vote to replace the Merit-Based Incentive Payment System (MIPS). The MedPAC’s recommendation, which if enacted by Congress would replace MIPS with a new value-based purchasing program, has left health care leaders speculating whether they need to reposition their Medicare strategies.
|
|||
Tim Gronniger, Caravan Health’s senior vice president of strategy and development, will lead the presentation to provide clarity around the potential policy changes and discuss how health care leaders can best position their hospitals for success. Attendees will also have the opportunity to ask their most pressing MIPS and policy-related questions.
“The MedPAC vote has left many of our ACO partners questioning how this could potentially affect their futures,” said Gronniger. “With many ideas bouncing around Washington D.C., we hope to clarify what’s happened and to provide counsel around what the future holds.”
The webinar will take place on Tuesday, January 30 at 12:00 p.m. PST/2:00 p.m. CST/3:00 p.m. EST. To register, visit the following link: https://caravanhealth.com/upcoming-events/.
About Caravan Health:
Caravan Health builds ACOs that jump-start population health programs with immediate quality and financial wins. Hospitals can finally get the high-quality scores, new competencies, and strong physician relationships that have been out of reach. By quickly producing positive results and accelerating health care transformation, Caravan Health engineers hospitals to succeed in population health payment models. For more information, visit caravanhealth.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47c33785-a5a7-4b61-9128-c6f94d394c0a
Sage Beard Caravan Health 916-542-4564 [email protected]


Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Anta Sports Expands Global Footprint With Strategic Puma Stake
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 



